- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01535339
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion
Mild traumatic brain injury (mTBI), also known as concussion, occurs commonly in sport. Despite ongoing research, there is no highly sensitive clinical test for cognitive function. This makes the clinical diagnosis of concussion particularly difficult as the clinical presentation of concussion is highly variable with symptoms often evolving over time. Given the variability in concussion presentations, there is no single test that can diagnose a concussion. Current recommendations are that sports medicine providers apply a multifaceted concussion assessment battery that combines subjective symptoms, motor control and cognitive assessment.
This investigation is designed to evaluate the clinical utility of ElMindA's BNA scores in detecting and managing concussive injuries. This study will establish the reliability of BNA™ scores over clinically relevant assessment intervals and investigate the effect of SRC and sub-concussive head impacts on BNA scores.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48105
- Michigan NeuroSport Concussion Program
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Phase 1: gender-balanced groups of 30 healthy high school (14-17 years old) and 30 healthy college aged (18-26 years old) individuals who participate in non-contact sports Phase 2a: 30 high school and/or collegiate athletes aged 14-26 years with concussion and 30 matched control athletes.
Phase 2b: at least 30 high school and/or collegiate contact sport athletes aged 14-26 years whose head impacts are monitored during games and practices.
Descripción
Phase 1:
Inclusion Criteria:
- Aged 14-26 years
- Enrolled in a recognized high school or college
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self)
- Currently participate in a non-contact sport.
- Member of an organized athletic team or regularly train for and participate in independent athletic contests during at least one sports season.
- Right handed subject
Exclusion Criteria:
- Currently participate in a contact sport.
- Bald or has dread locks/long and thick hair.
- Any diagnosed psychiatric disorder
- History of CNS injury or disease
- Any neuropsychological disorders
- History of learning disability.
- History of any medication affecting CNS.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a diagnosed concussion within the previous 6 months
Phase 2a:
Inclusion Criteria:
- Aged 14-26 years.
- For Arm 1: Within 1 week post-concussion (sports-related).
- For Arm 1: Currently symptomatic
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
- Member of an organized athletic team or regularly train.
- Enrolled in a high school or college.
Exclusion Criteria:
- Bald or has dread locks/long and thick hair.
- Current or history of ADHD.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a concussion within the past 6 months.
- Current or history of moderate or severe TBI, any brain injury with positive neuroimaging findings, or brain surgery.
Phase 2b:
Inclusion Criteria:
- Aged 14-26 years.
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
- Member of a contact sport team which carries out head impact monitoring over the course of the playing season.
- Enrolled in a high school or college.
Exclusion Criteria:
- Bald or has dread locks/long and thick hair.
- Current or history of ADHD.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a concussion within the past 6 months.
- Current or history of moderate or severe TBI, any brain injury with positive neuroimaging findings, or brain surgery.
- Any diagnosed psychiatric disorder.
- History of CNS injury or disease
- Any neuropsychological disorders.
- History of learning disability.
- History of any medication affecting CNS.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: Grupo
- Perspectivas temporales: Futuro
Cohortes e Intervenciones
Grupo / Cohorte |
---|
Phase I - Normative
Athletes who does not participate in contact sport with no recent concussion
|
Phase IIa - Concussed
Athletes with recent concussion
|
Phase IIa - Control
Athletes with no recent concussion
|
Phase IIb - Athletes
Athletes with no recent concussion
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Change of Brain Network Activation(BNA™)Scores
Periodo de tiempo: P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
---|---|
Correlation Of The Change In BNA™ Scores To Clinical Diagnstic
Periodo de tiempo: P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Correlation Of The Change In BNA™ Scores To Neurocognitive Tests Scroes
Periodo de tiempo: P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Correlation Of The Change In BNA™ Scores To Reaction Time Scores
Periodo de tiempo: P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ELM-03
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .